Swedbank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $651M | Sell |
1,298,760
-181,534
| -12% | -$87.1M | 0.56% | 35 |
|
|
2026
Q1 | $728M | Sell |
1,480,294
-194,108
| -12% | -$105M | 0.76% | 25 |
|
|
2025
Q4 | $970M | Sell |
1,674,402
-117,971
| -7% | -$66.7M | 0.94% | 17 |
|
|
2025
Q3 | $869M | Buy |
1,792,373
+108,315
| +6% | +$50.4M | 0.88% | 16 |
|
|
2025
Q2 | $683M | Buy |
1,684,058
+100,282
| +6% | +$41.9M | 0.77% | 21 |
|
|
2025
Q1 | $788M | Buy |
1,583,776
+160,621
| +11% | +$87M | 1.05% | 16 |
|
|
2024
Q4 | $740M | Buy |
1,423,155
+228,475
| +19% | +$126M | 0.91% | 19 |
|
|
2024
Q3 | $739M | Sell |
1,194,680
-8,770
| -0.7% | -$5.19M | 0.94% | 19 |
|
|
2024
Q2 | $666M | Sell |
1,203,450
-10,631
| -0.9% | -$6.09M | 0.89% | 21 |
|
|
2024
Q1 | $706M | Buy |
1,214,081
+8,173
| +0.7% | +$4.59M | 1% | 21 |
|
|
2023
Q4 | $640M | Sell |
1,205,908
-4,912
| -0.4% | -$2.38M | 1.03% | 20 |
|
|
2023
Q3 | $613M | Sell |
1,210,820
-161,468
| -12% | -$86M | 1.06% | 20 |
|
|
2023
Q2 | $716M | Buy |
1,372,288
+139,129
| +11% | +$75.1M | 1.21% | 16 |
|
|
2023
Q1 | $711M | Sell |
1,233,159
-14,669
| -1% | -$8.27M | 1.4% | 13 |
|
|
2022
Q4 | $687M | Sell |
1,247,828
-130,069
| -9% | -$68.9M | 1.51% | 11 |
|
|
2022
Q3 | $699M | Buy |
1,377,897
+100,229
| +8% | +$56.1M | 1.66% | 10 |
|
|
2022
Q2 | $694M | Buy |
1,277,668
+91,586
| +8% | +$50.4M | 1.57% | 10 |
|
|
2022
Q1 | $701M | Sell |
1,186,082
-141,375
| -11% | -$81.2M | 1.3% | 13 |
|
|
2021
Q4 | $883M | Sell |
1,327,457
-27,261
| -2% | -$17M | 1.48% | 14 |
|
|
2021
Q3 | $774M | Sell |
1,354,718
-16,704
| -1% | -$9.17M | 1.45% | 13 |
|
|
2021
Q2 | $692M | Buy |
1,371,422
+211,309
| +18% | +$99.7M | 1.3% | 12 |
|
|
2021
Q1 | $529M | Buy |
1,160,113
+168,833
| +17% | +$80.6M | 1.1% | 17 |
|
|
2020
Q4 | $458M | Buy |
991,280
+323,315
| +48% | +$152M | 1.34% | 18 |
|
|
2020
Q3 | $295M | Sell |
667,965
-8,645
| -1% | -$3.57M | 1.01% | 25 |
|
|
2020
Q2 | $245M | Buy |
676,610
+18,305
| +3% | +$6.14M | 0.89% | 26 |
|
|
2020
Q1 | $187M | Buy |
658,305
+12,957
| +2% | +$4.09M | 0.92% | 32 |
|
|
2019
Q4 | $210M | Sell |
645,348
-95,162
| -13% | -$28.9M | 0.85% | 34 |
|
|
2019
Q3 | $216M | Sell |
740,510
-42,345
| -5% | -$12.1M | 0.98% | 28 |
|
|
2019
Q2 | $230M | Buy |
782,855
+374,739
| +92% | +$103M | 1.04% | 26 |
|
|
2019
Q1 | $112M | Buy |
+408,116
| New | +$102M | 0.53% | 70 |
|
Other funds holding TMO
Swedbank's TMO Position: Q2 2026 in Review
Swedbank reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $87.1M and leaving 1,298,760 shares worth $651M. The position accounts for 0.56% of the portfolio, ranked #35.
Swedbank first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $970M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Swedbank held 1,298,760 shares of Thermo Fisher Scientific worth $651M as of Q2 2026.
- Swedbank sold 181,534 Thermo Fisher Scientific shares in Q2 2026, an estimated $87.1M.
- Thermo Fisher Scientific made up 0.56% of Swedbank's portfolio in Q2 2026, its #35 holding.
- Swedbank first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
- Swedbank's Thermo Fisher Scientific position peaked at $970M in Q4 2025.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.